Literature DB >> 17387611

Comparison of endoscopic ultrasound chronic pancreatitis criteria to the endoscopic secretin-stimulated pancreatic function test.

Darwin L Conwell1, Gregory Zuccaro, Edward Purich, Seymour Fein, John J Vargo, John A Dumot, Frederick VanLente, Rocio Lopez, Patricia Trolli.   

Abstract

Endosonography (EUS) has emerged as a major diagnostic tool in pancreatic imaging. Direct tests of pancreatic function are considered the most sensitive and accurate method to establish a diagnosis of chronic pancreatitis (CP), particularly when imaging studies are inconclusive. The aim of this study was to compare current EUS CP criteria with our newly described, purely endoscopic, secretin-stimulated pancreatic function test (ePFT). Fifty-six patients (25 male, mean age = 44 years) who were referred for evaluation/treatment of chronic abdominal pain with or without CP underwent both EUS and ePFT. The EUS protocol included the following: (1) EUS images were obtained in a standardized fashion from both gastric and duodenal stations, and (2) EUS images were scored independently by one of three therapeutic endoscopists for 0--9 parenchymal/ductal criteria as follows: 0-3 = normal, 4-5 = equivocal, >/=6 = definite CP. Endoscopic pancreatic function test (ePFT) protocol included the following: (1) upper endoscopy, (2) intravenous synthetic porcine secretin (0.2 mcg/kg, ChiRhoClin, Inc.) after test dose, (3) duodenal fluid aspirated every 15 min for 1 h, and (4) autoanalyzed for [HCO3] cutpoint of 80 mEq/L. According to EUS, 33 were normal, 13 equivocal, and 10 definite for CP. The mean peak [HCO3 -] range (in mEq/L) for each group was normal CP (83.7, range = 58-118), equivocal CP (68, range = 30-88), and definite CP (56, range=19-84). Using a peak [HCO3 -] of </=80 mEq/L as diagnostic for CP, the referent values (sensitivity%/specificity%) for EUS in the diagnosis of CP were normal (60/72), equivocal (36/94), and definite (26/100), respectively. An EUS score or greater than 5 had the best specificity (100%) and negative predictive value (100%). We conclude that endoscopic pancreatic function testing with secretin confirms that as EUS score increases, the peak pancreatic fluid bicarbonate decreases. We also conclude that EUS has excellent statistical inferences for diagnosing CP when at least 6 or more criteria are present. EUS as a screening test in patients with chronic abdominal pain and equivocal imaging studies may be of limited value.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387611     DOI: 10.1007/s10620-006-9469-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  17 in total

Review 1.  A clinician's perspective on chronic pancreatitis--2002.

Authors:  Robert H Hawes
Journal:  Rev Gastroenterol Disord       Date:  2002

2.  Effect of aging on the pancreatic ducts: a study based on endoscopic retrograde pancreatography.

Authors:  B S Anand; J C Vij; H S Mac; V Chowdhury; A Kumar
Journal:  Gastrointest Endosc       Date:  1989 May-Jun       Impact factor: 9.427

3.  Endoscopic ultrasonography of chronic pancreatitis and pancreatic pseudocysts.

Authors:  W R Lees
Journal:  Scand J Gastroenterol Suppl       Date:  1986

4.  EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia.

Authors:  A V Sahai; G Mishra; I D Penman; D Williams; M B Wallace; N Hadzijahic; A Pearson; A Vanvelse; B J Hoffman; R H Hawes
Journal:  Gastrointest Endosc       Date:  2000-08       Impact factor: 9.427

5.  Endoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumors.

Authors:  Michael J Levy; Thomas C Smyrk; Raghuram P Reddy; Jonathan E Clain; Gavin C Harewood; Michael L Kendrick; Randall K Pearson; Bret T Petersen; Elizabeth Rajan; Mark D Topazian; Kenneth K Wang; Maurits J Wiersema; Tony E Yusuf; Suresh T Chari
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

6.  Pancreatic fibrosis in chronic alcoholics and nonalcoholics without clinical pancreatitis.

Authors:  C S Pitchumoni; M Glasser; R M Saran; P Panchacharam; W Thelmo
Journal:  Am J Gastroenterol       Date:  1984-05       Impact factor: 10.864

7.  Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis.

Authors:  M F Catalano; S Lahoti; J E Geenen; W J Hogan
Journal:  Gastrointest Endosc       Date:  1998-07       Impact factor: 9.427

8.  An endoscopic pancreatic function test with synthetic porcine secretin for the evaluation of chronic abdominal pain and suspected chronic pancreatitis.

Authors:  Darwin L Conwell; Gregory Zuccaro; John J Vargo; Patricia A Trolli; Frederick Vanlente; Nancy Obuchowski; John A Dumot; Cathy O'laughlin
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

9.  Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controls.

Authors:  Massimo Raimondo; Mami Imoto; Eugene P DiMagno
Journal:  Clin Gastroenterol Hepatol       Date:  2003-09       Impact factor: 11.382

10.  An endoscopic pancreatic function test with cholecystokinin-octapeptide for the diagnosis of chronic pancreatitis.

Authors:  Darwin L Conwell; Gregory Zuccaro; John J Vargo; J Brad Morrow; Nancy Obuchowski; John A Dumot; Patricia A Trolli; Allison Burton; Cathy O'laughlin; Frederick Van Lente
Journal:  Clin Gastroenterol Hepatol       Date:  2003-05       Impact factor: 11.382

View more
  9 in total

1.  Endoscopic pancreatic function test using combined secretin and cholecystokinin stimulation for the evaluation of chronic pancreatitis.

Authors:  Ryan Law; Rocio Lopez; Adele Costanzo; Mansour A Parsi; Tyler Stevens
Journal:  Gastrointest Endosc       Date:  2012-01-26       Impact factor: 9.427

2.  Effect of the Duration of Chronic Pancreatitis on Pancreas Islet Yield and Metabolic Outcome Following Islet Autotransplantation.

Authors:  Morihito Takita; Luis F Lara; Bashoo Naziruddin; Rauf Shahbazov; Michael C Lawrence; Peter T Kim; Nicholas Onaca; James S Burdick; Marlon F Levy
Journal:  J Gastrointest Surg       Date:  2015-05-02       Impact factor: 3.452

Review 3.  Chronic pancreatitis: A diagnostic dilemma.

Authors:  Sinead N Duggan; Hazel M Ní Chonchubhair; Oladapo Lawal; Donal B O'Connor; Kevin C Conlon
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 4.  Endoscopic ultrasound in chronic pancreatitis: where are we now?

Authors:  Andrada Seicean
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 5.  Endoscopic ultrasound in the diagnosis and treatment of pancreatic disease.

Authors:  Christopher W Teshima; Gurpal S Sandha
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Defining the accuracy of secretin pancreatic function testing in patients with suspected early chronic pancreatitis.

Authors:  Gyanprakash Ketwaroo; Alphonso Brown; Benjamin Young; Rakhi Kheraj; Mandeep Sawhney; Koenraad J Mortele; Robert Najarian; Sumeet Tewani; Deborah Dasilva; Steven Freedman; Sunil Sheth
Journal:  Am J Gastroenterol       Date:  2013-05-28       Impact factor: 10.864

7.  Predictors of malignancy and recommended follow-up in patients with negative endoscopic ultrasound-guided fine-needle aspiration of suspected pancreatic lesions.

Authors:  Bret J Spier; Eric A Johnson; Deepak V Gopal; Terrence Frick; Michael M Einstein; Siobhan Byrne; Rebecca L Koscik; Jinn-Ing Liou; Terri Broxmeyer; Suzanne M Selvaggi; Patrick R Pfau
Journal:  Can J Gastroenterol       Date:  2009-04       Impact factor: 3.522

Review 8.  Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis.

Authors:  Y Issa; M A Kempeneers; H C van Santvoort; T L Bollen; S Bipat; M A Boermeester
Journal:  Eur Radiol       Date:  2017-01-27       Impact factor: 5.315

Review 9.  Diagnostic Endoscopic Ultrasound: Technique, Current Status and Future Directions.

Authors:  Tiing Leong Ang; Andrew Boon Eu Kwek; Lai Mun Wang
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.